Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Folk singer-songwriter Peter Yarrow, most known as a member of the trio Peter, Paul and Mary, has died at 86 years old. The ...

Paul G. Pinsky, the longtime state legislator who now heads the Maryland Energy Administration (MEA), told his staff Monday ...

From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, ...

If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...

Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.

Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.

Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...

In an interview with HT Lifestyle, Dr. Rajesh Kumar Reddy Adapala, Department of Uro – oncology & Robotics, Asian Institute ...

The department has added several blood and urinary tract cancers to the list of diseases considered to be related to service ...